Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, N.
Right arrow Articles by Ahlskog, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, N.
Right arrow Articles by Ahlskog, J. E.
Related Collections
Right arrow Nutritional
Right arrow Gait disorders/ataxia
Right arrow Peripheral neuropathy
Right arrow All Spinal Cord
NEUROLOGY 2004;63:33-39
© 2004 American Academy of Neurology

Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration

Neeraj Kumar, MD, John B. Gross, Jr., MD and J. Eric Ahlskog, PhD MD

From the Department of Neurology (Drs. Kumar and Ahlskog) and Division of Gastroenterology and Hepatology (Dr. Gross), Department of Medicine, Mayo Clinic, Rochester, MN.

Address correspondence and reprint requests to Dr. N. Kumar, 200 First Street, SW, Rochester, MN 55905; e-mail: kumar.neeraj{at}mayo.edu

Background: Copper deficiency in ruminants is known to cause an ataxic myelopathy. Copper deficiency as a cause of progressive myelopathy in adults is underrecognized.

Objective: To describe the clinical, biochemical, electrophysiologic, and imaging characteristics in 13 patients with myelopathy associated with copper deficiency.

Methods: The records of patients with a copper deficiency–associated myelopathy were reviewed. Clinical characteristics, laboratory investigations, and responses to therapeutic intervention were summarized.

Results: Thirteen such patients were found, 11 of them in a 15-month period. All patients presented with prominent gait difficulty, reflecting a sensory ataxia due to dorsal column dysfunction and lower limb spasticity. All patients had polyneuropathy. A high or high-normal serum zinc level was seen in 7 of the 11 patients for whom this information was available. Somatosensory evoked potential studies done in eight patients showed impaired conduction in central proprioceptive pathways. Dorsal column signal change on spine MRI was present in three patients. An initial clue to the diagnosis was a very low ceruloplasmin level; further tests of copper metabolism excluded Wilson disease. The cause remained unexplained in most patients. Oral copper supplementation restored normal or near-normal copper levels in 7 of the 12 patients in whom adequate follow-up data were available; parenteral supplementation restored normal level in 3 further patients. Copper supplementation prevented further neurologic deterioration, but the degree of actual improvement was variable.

Conclusions: Unrecognized copper deficiency appears to be a common cause of idiopathic myelopathy in adults. The clinical picture bears striking similarities to the syndrome of subacute combined degeneration associated with vitamin B12 deficiency. Early recognition and copper supplementation may prevent neurologic deterioration.


Received February 5, 2004. Accepted in final form March 10, 2004.




This article has been cited by other articles:


Home page
NeurologyHome page
A. Henri-Bhargava, C. Melmed, R. Glikstein, and H. M. Schipper
NEUROLOGIC IMPAIRMENT DUE TO VITAMIN E AND COPPER DEFICIENCIES IN CELIAC DISEASE
Neurology, September 9, 2008; 71(11): 860 - 861.
[Full Text] [PDF]


Home page
NeurologyHome page
H. Schaumburg and S. Herskovitz
Copper deficiency myeloneuropathy: A clue to clioquinol-induced subacute myelo-optic neuropathy?
Neurology, August 26, 2008; 71(9): 622 - 623.
[Full Text] [PDF]


Home page
NeurologyHome page
S. P. Nations, P. J. Boyer, L. A. Love, M. F. Burritt, J. A. Butz, G. I. Wolfe, L. S. Hynan, J. Reisch, and J. R. Trivedi
Denture cream: An unusual source of excess zinc, leading to hypocupremia and neurologic disease
Neurology, August 26, 2008; 71(9): 639 - 643.
[Abstract] [Full Text] [PDF]


Home page
PNHome page
S H Wong, M Boggild, T P Enevoldson, and N A Fletcher
Myelopathy but normal MRI: where next?
Practical Neurology, April 1, 2008; 8(2): 90 - 102.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Iverson, M. McKenzie, K. Juhasz-Pocsine, S. A. Rudnicki, R. L. Archer, and S. I. Harik
NEUROLOGIC COMPLICATIONS OF GASTRIC BYPASS SURGERY FOR MORBID OBESITY
Neurology, January 22, 2008; 70(4): 324 - 325.
[Full Text] [PDF]


Home page
haematolHome page
A.S. Haddad, V. Subbiah, A.E. Lichtin, K.S. Theil, and J.P. Maciejewski
Hypocupremia and bone marrow failure
Haematologica, January 1, 2008; 93(1): e1 - e5.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
T. Fong, R. Vij, A. Vijayan, J. DiPersio, and M. Blinder
Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome
Haematologica, October 1, 2007; 92(10): 1429 - 1430.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
M. P. Fuhrman
Micronutrient Assessment in Long-Term Home Parenteral Nutrition Patients
Nutr Clin Pract, December 1, 2006; 21(6): 566 - 575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
B.P. Goodman, B.W. Chong, A.C. Patel, G.P. Fletcher, and B.E. Smith
Copper Deficiency Myeloneuropathy Resembling B12 Deficiency: Partial Resolution of MR Imaging Findings with Copper Supplementation
AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2112 - 2114.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. L. Schlief, T. West, A. M. Craig, D. M. Holtzman, and J. D. Gitlin
Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity
PNAS, October 3, 2006; 103(40): 14919 - 14924.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin. Proc.Home page
N. Kumar
Copper Deficiency Myelopathy (Human Swayback)
Mayo Clin. Proc., October 1, 2006; 81(10): 1371 - 1384.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C I Prodan, S S Bottomley, N R Holland, and S E Lind
Relapsing hypocupraemic myelopathy requiring high-dose oral copper replacement.
J. Neurol. Neurosurg. Psychiatry, September 1, 2006; 77(9): 1092 - 1093.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
J. C. Tan, D. L. Burns, and H. R. Jones
Severe Ataxia, Myelopathy, and Peripheral Neuropathy Due to Acquired Copper Deficiency in a Patient With History of Gastrectomy
JPEN J Parenter Enteral Nutr, September 1, 2006; 30(5): 446 - 450.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P J Twomey, A Viljoen, I M House, T M Reynolds, and A S Wierzbicki
Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice
J. Clin. Pathol., August 1, 2006; 59(8): 867 - 869.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
N Kumar and J B Gross Jr
Mutation in the ATP7A gene may not be responsible for hypocupraemia in copper deficiency myelopathy.
Postgrad. Med. J., June 1, 2006; 82(968): 416 - 416.
[Full Text] [PDF]


Home page
NeurologyHome page
C. M. Everett, M. Matharu, and J. Gawler
Neuropathy progressing to myeloneuropathy 20 years after partial gastrectomy
Neurology, May 9, 2006; 66(9): 1451 - 1451.
[Full Text] [PDF]


Home page
J Am Board Fam MedHome page
J. Wu, M. Ricker, and J. Muench
Copper Deficiency as Cause of Unexplained Hematologic and Neurologic Deficits in Patient with Prior Gastrointestinal Surgery
J Am Board Fam Med, March 1, 2006; 19(2): 191 - 194.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin. Proc.Home page
N. Kumar
'Myelodysplasia,' Myeloneuropathy, and Copper Deficiency-Reply-I
Mayo Clin. Proc., January 1, 2006; 81(1): 132 - 132.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Rowin and S L Lewis
Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation
J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 750 - 751.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
N Kumar and D S Knopman
SMON, clioquinol, and copper
Postgrad. Med. J., April 1, 2005; 81(954): 227 - 227.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.